Neurocrine Biosciences
NBIX
#1506
Rank
ยฃ8.98 B
Marketcap
ยฃ90.08
Share price
-3.57%
Change (1 day)
-14.35%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.84 Billion

According to Neurocrine Biosciences 's latest financial reports the company has ยฃ0.84 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.80 B-0.98%
2022-12-31ยฃ0.81 B55.18%
2021-12-31ยฃ0.52 B-10.33%
2020-12-31ยฃ0.58 B14.93%
2019-12-31ยฃ0.51 B-0.29%
2018-12-31ยฃ0.51 B34.33%
2017-12-31ยฃ0.38 B53.26%
2016-12-31ยฃ0.24 B-2.65%
2015-12-31ยฃ0.25 B105.55%
2014-12-31ยฃ0.12 B40.89%
2013-12-31ยฃ88.35 M-17.46%
2012-12-31ยฃ0.10 B28.87%
2011-12-31ยฃ83.06 M1.07%
2010-12-31ยฃ82.18 M148.74%
2009-12-31ยฃ33.03 M-39.83%
2008-12-31ยฃ54.9 M-39.19%
2007-12-31ยฃ90.29 M-3.14%
2006-12-31ยฃ93.22 M-41.13%
2005-12-31ยฃ0.15 B0.95%
2004-12-31ยฃ0.15 B-38.08%
2003-12-31ยฃ0.25 B65.99%
2002-12-31ยฃ0.15 B-30.85%
2001-12-31ยฃ0.22 B100.03%
2000-12-31ยฃ0.11 B95.69%
1999-12-31ยฃ56.38 M701.28%
1998-12-31ยฃ7.03 M-26.84%
1997-12-31ยฃ9.61 M45.75%
1996-12-31ยฃ6.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.61 B-27.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.39 B 64.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ2.68 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.69 B 218.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.37 B 416.22%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.83 B 824.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.12 B-85.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.8 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA